17,70 €
2,15 %gestern
L&S, 28. Februar, 22:53 Uhr
ISIN
US2289031005
Symbol
CRY
Berichte

CryoLife Aktie News

Neutral
PRNewsWire
etwa 2 Jahre alt
ATLANTA, Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the words "aorta", "innovation", and "vision", the company's new name and brand reflect its evolution to focus on providing innovative technol...
Positiv
GuruFocus
mehr als 2 Jahre alt
Value investors may find the following stocks to be attractive opportunities, as they have low price-sales ratios compared to the S&P 500 and good profitability.
Neutral
Seeking Alpha
mehr als 2 Jahre alt
CryoLife, Inc. (CRY) CEO J. Patrick Mackin on Q3 2021 Results - Earnings Call Transcript
Neutral
PRNewsWire
mehr als 2 Jahre alt
ATLANTA, Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results will be released on Thursday, November 4, 2021 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m.
Neutral
PRNewsWire
mehr als 2 Jahre alt
ATLANTA, Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo to its Board of Directors effective October 1, 2021.
Neutral
PRNewsWire
mehr als 2 Jahre alt
ATLANTA, Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021. The Company's virtual fireside chat is scheduled to begin at 12:30 p.m.
Neutral
PRNewsWire
mehr als 2 Jahre alt
ATLANTA, Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences. CryoLife's management team will present at the upcoming Canaccord Genuity 41st Annual Growth Conference on Wednesday, August 11, 2021.
Neutral
PRNewsWire
mehr als 2 Jahre alt
ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results will be released on Thursday, July 29, 2021 after the market closes.  On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen